What is King Pharmaceuticals's operating lease ROU assets?

King Pharmaceuticals (KG) reported operating lease ROU assets of 7.2% in Q1 2026.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

King Pharmaceuticals KG Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

SiriusPointSPNT

3.3%+0.3pp

Verisk Analytics, Inc.VRSK

$132.7M-12.6%

Silvercrest Asset Management GroupSAMG

5.4%+0.7pp

LazardLAZ

$402.5M-6.5%

Tiptree Inc.TIPT

——

W.R. BerkleyWRB

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's operating lease ROU assets?: King Pharmaceuticals (KG) reported operating lease ROU assets of 7.2% in Q1 2026.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.